The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement-control protein-CR2 chimeras
Anna Ansaba Johnson, Ariella Mirowski Rosengard, Karsten Skjødt, Joseph Michael Ahearn, Robert Graham Quinton LeslieVolume:
29
Year:
1999
Language:
english
Pages:
8
DOI:
10.1002/(sici)1521-4141(199912)29:123.0.co;2-k
File:
PDF, 148 KB
english, 1999